<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">PAR</journal-id><journal-title-group><journal-title>Proceedings of Anticancer Research</journal-title></journal-title-group><issn>2208-3545</issn><eissn>2208-3553</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/par.v5i4.2331</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Clinical Analysis of 15 Cases of Non-Hodgkin Lymphoma Complicated with Pneumocystis carinii Pneumonia Treated with R-CHOP Regimen </title><url>https://artdesignp.com/journal/PAR/5/4/10.26689/par.v5i4.2331</url><author>GuoXiaohua,HuLinjun,XingSijia,ZhouLiqiang</author><pub-date pub-type="publication-year"><year>2021</year></pub-date><volume>5</volume><issue>4</issue><history><date date-type="pub"><published-time>2021-07-29</published-time></date></history><abstract>Objective: To investigate the clinical features of R-CHOP regimen in the treatment of non-Hodgkin’s lymphoma with Pneumocystis carinii pneumonia (PCP) in order to improve the understanding of PCP and the side effects of Rituxan. Methods: A retrospective analysis of 90 patients with non-Hodgkin’s lymphoma treated with R-CHOP chemotherapy in our hospital from November 2015 to November 2020, of which 15 (16.7%) patients, combined with PCP clinical data, including clinical symptoms, physical signs, chest imaging examination and treatment data were used for to analysis and summarization. Results: The clinical features of R-CHOP chemotherapy combined with PCP were fever, cough, and sputum. Some patients had fewer clinical symptoms. Common imaging manifestations were double lung membrane glass shadow, patchy shadow, and flocculent shadow. It can occur in all clinical stages, and the incidence of late stage is high, and there is no clear correlation with bone marrow suppression. Pneumocystis was found in 2 cases of sputum, and the rest of the patients were clinically diagnosed. The main therapeutic drugs are sulfamethoxazole (8/15), compound sulfamethoxazole (6/15), clindamycin (1/15, sulfa drug allergy), and adrenal cortex hormones (4/15). Fourteen cases were cured and 1 case died. Conclusion: The incidence of R-CHOP in advanced non-Hodgkin’s lymphoma of PCP is high. Patients with clinical use of R-CHOP chemotherapy will encounter fever, cough, chest computed tomography (CT) film glass shadow, and diffuse patch shadow. Patients should be alert to the possibility of PCP and take sulfonamides as soon as possible for medical treatment.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Coiffier B, Lepage E, Briere J, et al., 2002, CHOP Chemotherapy Plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma. N Engl J Med, 346(4): 235-242.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Marcus R, Davies A, Ando K, et al., 2017, Obinutuzumab for the First-Line Treatment of Follicular Lymphoma. N Engl J Med, 377(14): 1331-1344.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Spina V, Rossi D, 2017, Molecular Pathogenesis of Splenic and Nodal Marginal Zone Lymphoma. Best Pract Res Clin Haematol, 30(1-2): 5-12.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Swerdlow SH, Campo E, Pileri SA, et al., 2016, The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms. Blood, 127(20): 2375-2390.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Zhang S, Liu L, Wang MJ, et al., 2015, Treatment Strategies of Pathogenic Microbiology Screening Agents for Patients with Carinii and/or Cytomegalovirus Pneumonia. Journal of the Third Military Medical University, 37(19): 1976-1977.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Zeng CL, Yuan G, Xiang H, 2013, Survival Analysis of AIDS Patients with Severe Pneumonia Caused by Castella spp. Disease Surveillance, 28(1): 83-84.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Wu HH, Li YP, Chen CS, et al., 2013, Study on Serological Indexes of Pneumocystis Carinii Pneumonia. Chinese Journal of Nosocomial Infection, 8(1): 123-124.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Castaner E, Gallardo X, Mata JM, et al., 2004, Radiologic Approach to the Diagnosis of Infectious Pulmonary Diseases in Patients Infected with the Human Immunodeficiency Virus. Eur J Radiol, 51(2): 114-129.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Tokuda H, Sakai F, Yamada H, et al., 2008, Clinical and Radiological Features of Pneumocystis Pneumonia in Patients with Rheumatoid Arthritis, in Comparison with Methotrexate Pneumonitis and Pneumocystis Pneumonia in Acquired Immunodeficiency Syndrome: A Multicenter Study. Intern Med, 47(10): 915-923.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Zhai JM, He LX, Li XY, 1991, Diagnosis and Progress of Pneumocystis carinii Pneumonia. Chinese Journal of Tuberculosis and Respiratory, 14: 236-237.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Guo Y, Liu AS, 2013, CT Image Analysis of AIDS Complicated with Pneumocystis carinii Pneumonia. Chinese Journal of Experimental and Clinical Infectious Diseases, 7(1): 33-36.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Feng Y, Ding H, Chen RH, 2012, Two Cases of Pneumocystis carinii Pneumonia and Literature Review. Chinese Journal of Clinicians, 6(2): 514-515.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Lu JJ, Lee CH, 2008, Pneumocystis Pneumonia. J Formos Med Assoc, 107(11): 830-842.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Zhu B, Xiang H, Gan MZ, et al., 2016, Observation on the Efficacy of Reduced-Dose Rituximab Combined with CHOP Regimen in the Treatment of Elderly Diffuse Large B-Cell Lymphoma. International Journal of Blood Transfusion and Hematology, 39(2): 93-99.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
